Drug excipients and label inconsistencies with Data Scientist Mike Brook

In this discussion, data scientist Mike Brook highlights inconsistencies in the listing of drug excipients on DailyMed, a resource commonly used by patients with sensitivities to medications, and how this may impact individuals with conditions like POTS, MCAS, and others. The research finds that about 40% of DailyMed drug labels exhibit inconsistencies in inactive ingredient lists, revealing gaps in reliable data for sensitive patients. For patients experiencing adverse reactions, it's recommended to review both sections of the excipient listings and potentially contact manufacturers for accurate information. The project encourages looking at alternative formulations or working with compounding pharmacies to control excipients for better patient outcomes. This research stresses the importance of diligent checking when managing medication due to potential inaccuracies in excipient data, which can affect patient health significantly.